Related Experiment Video
Updated: Aug 29, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
Buried alive: a novel approach to cancer treatment
Bengt Fadeel1, Sten Orrenius, Shazib Pervaiz
1Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Stockholm, Sweden.
Abstract:
The heightened interest in the development of novel anti-cancer drugs that trigger apoptotic death in cancer cells stems from the fact that immediately upon execution of the death signal, the corpse is efficiently removed via specific recruitment of phagocytic cells. This prevents spilling of cellular contents and the associated inflammatory response, a likely scenario during necrotic death. Recent evidence has established that phagocytic removal of apoptotic cells is a function of ligand-receptor interaction, whereby the ligand(s) for the scavenger receptor(s) of phagocytic cells is/are specifically expressed on apoptosing cells. Therefore, by implication, enhancing this ligand-receptor interaction could be an alternate means for removing unwanted cells. Here we present a provocative hypothesis that circumvents the need for chemotherapy-induced apoptosis in cancer cells. According to our model, cancer cells need not die in order to be removed by scavenger cells, but could still be effectively phagocytosed provided the cell surface expression of specific molecules that strongly engage phagocytic cells is sufficiently enhanced. In other words, inducing the expression of "eat me" signals on cancer cells could be a novel approach to "bury alive" these unwanted cells without the untoward effects of chemotherapy-induced apoptosis.
Insights
Cancer cells can be removed without inducing apoptosis. Enhancing "eat me" signals on cancer cells promotes phagocytosis, offering a novel anti-cancer strategy without chemotherapy side effects.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Apoptotic cell death is preferred over necrosis due to efficient clearance by phagocytic cells, preventing inflammation.
- Phagocytic removal of apoptotic cells relies on ligand-receptor interactions between apoptotic cells and scavenger receptors on phagocytes.
- Current anti-cancer drug development focuses on inducing apoptosis for efficient cellular removal.
Purpose of the Study:
- To propose a novel hypothesis for cancer cell removal that bypasses the need for chemotherapy-induced apoptosis.
- To explore enhancing "eat me" signals on cancer cells for phagocytic engulfment.
- To present an alternative strategy for eliminating cancer cells without the adverse effects of traditional chemotherapy.
Main Methods:
- This study presents a theoretical model and hypothesis, not experimental methods.
- The hypothesis focuses on modulating cell surface molecule expression.
- The proposed mechanism involves enhancing "eat me" signals on cancer cells.
Main Results:
- Cancer cells can be phagocytosed without undergoing apoptosis if "eat me" signals are sufficiently enhanced.
- This approach aims to achieve efficient removal of cancer cells by phagocytes.
- The proposed method circumvents the inflammatory risks associated with necrotic cell death.
Conclusions:
- Enhancing "eat me" signals on cancer cells offers a novel therapeutic strategy.
- This approach could lead to the "burial alive" of cancer cells via phagocytosis.
- This method avoids the toxicities and inflammatory responses associated with chemotherapy-induced apoptosis.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Treatment Resistent Cancers
